|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
||
This patient referral form is provided for the use and convenience of physicians and their office personnel only. The slip contains all the necessary information to refer a patient for bone density testing at the OOC.
Dear Colleague:
Our clinical research unit has actively evaluated new treatments and treatment regimens for osteoporosis for the past 12 years. We are currently enrolling subjects in several clinical research studies. The evaluation of subjects for study entry, including bone density testing, routine laboratory studies and study medications are provided at no cost to the participants. Being a part of one of our studies does not interfere with the relationship between the research subjects and his or her primary care provider. We work diligently to communicate regularly and effectively with the subject's physician, and we forward the results of study laboratory procedures to the health care provider at regular intervals.
For more information about the specific studies we are condicting at this time, please call me at (503) 215-6456 or call Dr. Molly Omizo at (503) 215-1616.
If patients are interested in more information or to discuss study participation, please direct their calls to our recruitment coordinator at (503) 215-1731.
Michael McClung, MD
Director, Oregon Osteoporosis Center
